Pinter, Matthias

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis

Cited by 1,294

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 545

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

Yau, T., Galle, P. R., Decaens, T., Sangro, B., Qin, S., da Fonseca, L. G., Karachiwala, H., Blanc, J.-F., Park, J.-W., Gane, E., et al. (2025) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 390

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

Incio, J., Ligibel, J. A., McManus, D. T., Suboj, P., Jung, K., Kawaguchi, K., Pinter, M., Babykutty, S., Chin, S. M., Vardam, T. D., et al. (2018) · Science Translational Medicine

Angiogenesis and VEGF in CancerLymphatic System and Diseases

Cited by 222

Targeting CXCR4-dependent immunosuppressive Ly6C low monocytes improves antiangiogenic therapy in colorectal cancer

Jung, K., Heishi, T., Incio, J., Huang, Y., Beech, E. Y., Pinter, M., Ho, W. W., Kawaguchi, K., Rahbari, N. N., Chung, E., et al. (2017) · Proceedings of the National Academy of Sciences

Angiogenesis and VEGF in CancerChemokine receptors and signaling

Cited by 138

NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy

Pinter, M., Pinato, D. J., Ramadori, P., & Heikenwalder, M. (2023) · Clinical Cancer Research

Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis

Cited by 103

Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma

Liu, H., Naxerova, K., Pinter, M., Incio, J., Lee, H., Shigeta, K., Ho, W. W., Crain, J. A., Jacobson, A., Michelakos, T., et al. (2017) · Clinical Cancer Research

Pancreatic and Hepatic Oncology ResearchPeptidase Inhibition and Analysis

Cited by 96

Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma

Schulte, L., Scheiner, B., Voigtländer, T., Koch, S., Schweitzer, N., Marhenke, S., Ivanyi, P., Manns, M. P., Rodt, T., Hinrichs, J. B., et al. (2019) · Liver International

Metabolism, Diabetes, and CancerHepatocellular Carcinoma Treatment and Prognosis

Cited by 67

Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information

Stift, J., Semmler, G., Walzel, C., Mandorfer, M., Schwarzer, R., Schwabl, P., Paternostro, R., Scheiner, B., Wöran, K., Pinter, M., et al. (2019) · Digestive and Liver Disease

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 34

Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy

Stift, J., Semmler, G., Wöran, K., Simbrunner, B., Scheiner, B., Schwabl, P., Paternostro, R., Pinter, M., Stättermayer, A. F., Meischl, T., et al. (2020) · Digestive and Liver Disease

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 16